The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) today announced a research partnership with MitoQ New Zealand to examine the potential role of MitoQ® (mitoquinol mesylate), a mitochondria-targeted antioxidant, in supporting healthy ageing. Building on existing scientific literature, the partnership aims to generate evidence on whether MitoQ® can slow or improve markers of biological ageing and support longevity potential. The joint study will also evaluate the effectiveness of biological ageing clocks in assessing health supplements and other interventions more rapidly than conventional long-term clinical trials.

The UK‑led OpenBind initiative has reached a major milestone with the release of its first publicly available dataset , a groundbreaking step toward accelerating the discovery of new medicines using artificial intelligence. The release makes high‑quality, standardised experimental data freely accessible to researchers worldwide, providing AI-ready data to address the most persistent barriers in AI‑driven therapeutic development.

People with self-reported poorer mental health also report worse quality of care and lower confidence in healthcare systems, according to a study published May 5^th in the open-access journal PLOS Medicine by Margaret E. Kruk from Washington University in St. Louis, U.S., and colleagues.

The H5N1 strain of highly pathogenic avian influenza H5N1 has been detected in over 700 herds of dairy cows in California, the largest dairy-producing state in the U.S. A study published May 5^th in the open-access journal PLOS Biology led by Seema S. Lakdawala at Emory University School of Medicine, U.S. and Jason Lombard at Colorado State University, U.S. suggests that avian influenza (H5N1) is transmitted through multiple, previously unknown sources and that some H5N1 positive cows do not show clinical signs of infection.

Only 43% of menu items at the UK’s highest-grossing restaurant chains met all their voluntary targets for sugar, salt, and calorie reduction, as set by the UK Government. These findings are published on May 5^th in a study in the open-access journal PLOS Medicine by Alice O’Hagan of the University of Oxford, UK, and colleagues.

Researchers have developed methods using induced pluripotent stem cells and CRISPR gene editing to evaluate how genetic variants elsewhere in an individual's genome — their genetic background — work with a deletion on chromosome 16 that is associated with various neurodevelopmental outcomes to help determine the features that the individual will develop.